Cargando…
Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease for which age is the most important risk factor. Different mechanisms associated with aging, including stem cell dysfunction, have been described to participate in the pathophysiology of IPF. We observed an extrapulmonary effe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158816/ https://www.ncbi.nlm.nih.gov/pubmed/30257725 http://dx.doi.org/10.1186/s13287-018-0970-6 |
_version_ | 1783358490300907520 |
---|---|
author | Cárdenes, Nayra Álvarez, Diana Sellarés, Jacobo Peng, Yating Corey, Catherine Wecht, Sophie Nouraie, Seyed Mehdi Shanker, Swaroop Sembrat, John Bueno, Marta Shiva, Sruti Mora, Ana L. Rojas, Mauricio |
author_facet | Cárdenes, Nayra Álvarez, Diana Sellarés, Jacobo Peng, Yating Corey, Catherine Wecht, Sophie Nouraie, Seyed Mehdi Shanker, Swaroop Sembrat, John Bueno, Marta Shiva, Sruti Mora, Ana L. Rojas, Mauricio |
author_sort | Cárdenes, Nayra |
collection | PubMed |
description | BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease for which age is the most important risk factor. Different mechanisms associated with aging, including stem cell dysfunction, have been described to participate in the pathophysiology of IPF. We observed an extrapulmonary effect associated with IPF: increase in cell senescence of bone marrow-derived mesenchymal stem cells (B-MSCs). METHODS: B-MSCs were obtained from vertebral bodies procured from IPF patients and age-matched normal controls. Cell senescence was determined by cell proliferation and expression of markers of cell senescence p16(INK4A), p21, and β-galactosidase activity. Mitochondrial function and DNA damage were measured. Paracrine induction of senescence and profibrotic responses were analyzed in vitro using human lung fibroblasts. The reparative capacity of B-MSCs was examined in vivo using the bleomycin-induced lung fibrosis model. RESULTS: In our study, we demonstrate for the first time that B-MSCs from IPF patients are senescent with significant differences in mitochondrial function, with accumulation of DNA damage resulting in defects in critical cell functions when compared with age-matched controls. Senescent IPF B-MSCs have the capability of paracrine senescence by inducing senescence in normal-aged fibroblasts, suggesting a possible link between senescent B-MSCs and the late onset of the disease. IPF B-MSCs also showed a diminished capacity to migrate and were less effective in preventing fibrotic changes observed in mice after bleomycin-induced injury, increasing illness severity and proinflammatory responses. CONCLUSIONS: We describe extrapulmonary alterations in B-MSCs from IPF patients. The consequences of having senescent B-MSCs are not completely understood, but the decrease in their ability to respond to normal activation and the risk of having a negative impact on the local niche by inducing inflammation and senescence in the neighboring cells suggests a new link between B-MSC and the onset of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-018-0970-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6158816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61588162018-10-01 Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis Cárdenes, Nayra Álvarez, Diana Sellarés, Jacobo Peng, Yating Corey, Catherine Wecht, Sophie Nouraie, Seyed Mehdi Shanker, Swaroop Sembrat, John Bueno, Marta Shiva, Sruti Mora, Ana L. Rojas, Mauricio Stem Cell Res Ther Research BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease for which age is the most important risk factor. Different mechanisms associated with aging, including stem cell dysfunction, have been described to participate in the pathophysiology of IPF. We observed an extrapulmonary effect associated with IPF: increase in cell senescence of bone marrow-derived mesenchymal stem cells (B-MSCs). METHODS: B-MSCs were obtained from vertebral bodies procured from IPF patients and age-matched normal controls. Cell senescence was determined by cell proliferation and expression of markers of cell senescence p16(INK4A), p21, and β-galactosidase activity. Mitochondrial function and DNA damage were measured. Paracrine induction of senescence and profibrotic responses were analyzed in vitro using human lung fibroblasts. The reparative capacity of B-MSCs was examined in vivo using the bleomycin-induced lung fibrosis model. RESULTS: In our study, we demonstrate for the first time that B-MSCs from IPF patients are senescent with significant differences in mitochondrial function, with accumulation of DNA damage resulting in defects in critical cell functions when compared with age-matched controls. Senescent IPF B-MSCs have the capability of paracrine senescence by inducing senescence in normal-aged fibroblasts, suggesting a possible link between senescent B-MSCs and the late onset of the disease. IPF B-MSCs also showed a diminished capacity to migrate and were less effective in preventing fibrotic changes observed in mice after bleomycin-induced injury, increasing illness severity and proinflammatory responses. CONCLUSIONS: We describe extrapulmonary alterations in B-MSCs from IPF patients. The consequences of having senescent B-MSCs are not completely understood, but the decrease in their ability to respond to normal activation and the risk of having a negative impact on the local niche by inducing inflammation and senescence in the neighboring cells suggests a new link between B-MSC and the onset of the disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-018-0970-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-26 /pmc/articles/PMC6158816/ /pubmed/30257725 http://dx.doi.org/10.1186/s13287-018-0970-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Cárdenes, Nayra Álvarez, Diana Sellarés, Jacobo Peng, Yating Corey, Catherine Wecht, Sophie Nouraie, Seyed Mehdi Shanker, Swaroop Sembrat, John Bueno, Marta Shiva, Sruti Mora, Ana L. Rojas, Mauricio Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
title | Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
title_full | Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
title_fullStr | Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
title_full_unstemmed | Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
title_short | Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
title_sort | senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158816/ https://www.ncbi.nlm.nih.gov/pubmed/30257725 http://dx.doi.org/10.1186/s13287-018-0970-6 |
work_keys_str_mv | AT cardenesnayra senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT alvarezdiana senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT sellaresjacobo senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT pengyating senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT coreycatherine senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT wechtsophie senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT nouraieseyedmehdi senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT shankerswaroop senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT sembratjohn senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT buenomarta senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT shivasruti senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT moraanal senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis AT rojasmauricio senescenceofbonemarrowderivedmesenchymalstemcellsfrompatientswithidiopathicpulmonaryfibrosis |